as 11-21-2024 10:35am EST
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.
Founded: | 2005 | Country: | United States |
Employees: | N/A | City: | ROCHESTER HILLS |
Market Cap: | 136.2M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 94.3K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.07 | EPS Growth: | 60.96 |
52 Week Low/High: | $5.74 - $10.99 | Next Earning Date: | 11-07-2024 |
Revenue: | $132,783,999 | Revenue Growth: | 8.17% |
Revenue Growth (this year): | 10.49% | Revenue Growth (next year): | 8.84% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Eichenbaum Kenneth D. | INFU | Director | Sep 23 '24 | Buy | $5.89 | 4,000 | $23,560.00 | 4,000 |
INFU Breaking Stock News: Dive into INFU Ticker-Specific Updates for Smart Investing
Business Wire
3 days ago
Thomson Reuters StreetEvents
13 days ago
GuruFocus.com
13 days ago
Business Wire
14 days ago
GuruFocus.com
15 days ago
Business Wire
21 days ago
GuruFocus.com
a month ago
TipRanks
2 months ago
The information presented on this page, "INFU InfuSystems Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.